CSL Biotherapies Files Flu Vaccine BLA
This article was originally published in PharmAsia News
Executive Summary
Global influenza vaccine manufacturer CSL Biotherapies submitted a BLA March 30 seeking U.S. approval of its seasonal flu vaccine for healthy adults 18 and older, the company announced April 3